Tokyo Tape
Sign in
← I'rom Group

Quarterly report · Q1

2372.TEDINET S100RJUD
Period2023-04-01 → 2023-06-30
Filed2023-08-07
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
MetricValuePeriodScopeSource row
Revenue¥4.7bn2023-04-01 → 2023-06-30Cons.Net sales
Revenue¥18.4bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥4.8bn2022-04-01 → 2022-06-30Cons.Net sales
Operating income¥737m2023-04-01 → 2023-06-30Cons.Operating income
Operating income¥1.4bn2022-04-01 → 2022-06-30Cons.Operating income
Ordinary income¥1.1bn2023-04-01 → 2023-06-30Cons.Ordinary income
Ordinary income¥3.3bn2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥1.4bn2022-04-01 → 2022-06-30Cons.Ordinary income
Profit before tax¥1.2bn2023-04-01 → 2023-06-30Cons.Income before income taxes
Profit before tax¥1.5bn2022-04-01 → 2022-06-30Cons.Income before income taxes
Net income (owners)¥891m2023-04-01 → 2023-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥2.5bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥1.1bn2022-04-01 → 2022-06-30Cons.Profit loss attributable to owners of parent
Net income¥891m2023-04-01 → 2023-06-30Cons.Profit loss
Net income¥1.1bn2022-04-01 → 2022-06-30Cons.Profit loss
Total assets¥36.1bnat 2023-06-30Cons.Assets
Total assets¥35.1bnat 2023-03-31Cons.Assets
Total assets¥28.2bnat 2022-06-30Cons.Total assets (5-year summary)
Total liabilities¥23.3bnat 2023-06-30Cons.Liabilities
Total liabilities¥23.0bnat 2023-03-31Cons.Liabilities
Net assets / equity¥12.8bnat 2023-06-30Cons.Net assets
Net assets / equity¥12.2bnat 2023-03-31Cons.Net assets
Net assets / equity¥11.0bnat 2022-06-30Cons.Net assets (5-year summary)
Cash and deposits¥8.5bnat 2023-06-30Cons.Cash and deposits
Cash and deposits¥9.4bnat 2023-03-31Cons.Cash and deposits
EPS (basic)¥73.662023-04-01 → 2023-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥210.222022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥88.372022-04-01 → 2022-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥210.062022-04-01 → 2023-03-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥88.222022-04-01 → 2022-06-30Cons.Diluted earnings per share (5-year summary)
Equity ratio35.3%at 2023-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio34.6%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio38.9%at 2022-06-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 62
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2023-04-01 → 2023-06-30¥86m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2023-04-01 → 2023-06-30¥70m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2023-04-01 → 2023-06-30¥15m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-04-01 → 2023-06-30−¥212m
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-06-30−¥774m
Reconciling Itemsreconcilingrevenue intersegment2023-04-01 → 2023-06-30−¥774m
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-06-30−¥328m
jpcrp040300-q1r_E05352-000Advanced Medicinal Treatmentreportable segmentrevenue2023-04-01 → 2023-06-30¥875m
jpcrp040300-q1r_E05352-000Advanced Medicinal Treatmentreportable segmentrevenue external2023-04-01 → 2023-06-30¥605m
jpcrp040300-q1r_E05352-000Advanced Medicinal Treatmentreportable segmentrevenue intersegment2023-04-01 → 2023-06-30¥269m
jpcrp040300-q1r_E05352-000Advanced Medicinal Treatmentreportable segmentsegment profit2023-04-01 → 2023-06-30¥190m
jpcrp040300-q1r_E05352-000CROreportable segmentrevenue2023-04-01 → 2023-06-30¥1.6bn
jpcrp040300-q1r_E05352-000CROreportable segmentrevenue external2023-04-01 → 2023-06-30¥1.4bn
jpcrp040300-q1r_E05352-000CROreportable segmentrevenue intersegment2023-04-01 → 2023-06-30¥137m
jpcrp040300-q1r_E05352-000CROreportable segmentsegment profit2023-04-01 → 2023-06-30¥36m
jpcrp040300-q1r_E05352-000Medical Supportreportable segmentrevenue2023-04-01 → 2023-06-30¥453m
jpcrp040300-q1r_E05352-000Medical Supportreportable segmentrevenue external2023-04-01 → 2023-06-30¥277m
jpcrp040300-q1r_E05352-000Medical Supportreportable segmentrevenue intersegment2023-04-01 → 2023-06-30¥176m
jpcrp040300-q1r_E05352-000Medical Supportreportable segmentsegment profit2023-04-01 → 2023-06-30−¥49m
jpcrp040300-q1r_E05352-000SMOreportable segmentrevenue2023-04-01 → 2023-06-30¥2.5bn
jpcrp040300-q1r_E05352-000SMOreportable segmentrevenue external2023-04-01 → 2023-06-30¥2.3bn
jpcrp040300-q1r_E05352-000SMOreportable segmentrevenue intersegment2023-04-01 → 2023-06-30¥174m
jpcrp040300-q1r_E05352-000SMOreportable segmentsegment profit2023-04-01 → 2023-06-30¥1.1bn
—segment totalrevenue2023-04-01 → 2023-06-30¥5.3bn
—segment totalrevenue external2023-04-01 → 2023-06-30¥4.6bn
—segment totalrevenue intersegment2023-04-01 → 2023-06-30¥758m
—segment totalsegment profit2023-04-01 → 2023-06-30¥1.3bn
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-06-30¥5.4bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-06-30¥4.7bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-04-01 → 2023-06-30¥774m
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-06-30¥1.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-04-01 → 2022-06-30¥23m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-04-01 → 2022-06-30¥3m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2022-04-01 → 2022-06-30¥19m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-04-01 → 2022-06-30−¥45m
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-06-30−¥357m
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-06-30−¥357m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-06-30−¥364m
jpcrp040300-q1r_E05352-000Advanced Medicinal Treatmentreportable segmentrevenue2022-04-01 → 2022-06-30¥370m
jpcrp040300-q1r_E05352-000Advanced Medicinal Treatmentreportable segmentrevenue external2022-04-01 → 2022-06-30¥359m
jpcrp040300-q1r_E05352-000Advanced Medicinal Treatmentreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥10m
jpcrp040300-q1r_E05352-000Advanced Medicinal Treatmentreportable segmentsegment profit2022-04-01 → 2022-06-30¥40m
jpcrp040300-q1r_E05352-000CROreportable segmentrevenue2022-04-01 → 2022-06-30¥1.3bn
jpcrp040300-q1r_E05352-000CROreportable segmentrevenue external2022-04-01 → 2022-06-30¥1.3bn
jpcrp040300-q1r_E05352-000CROreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥75m
jpcrp040300-q1r_E05352-000CROreportable segmentsegment profit2022-04-01 → 2022-06-30¥61m
jpcrp040300-q1r_E05352-000Medical Supportreportable segmentrevenue2022-04-01 → 2022-06-30¥483m
jpcrp040300-q1r_E05352-000Medical Supportreportable segmentrevenue external2022-04-01 → 2022-06-30¥256m
jpcrp040300-q1r_E05352-000Medical Supportreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥226m
jpcrp040300-q1r_E05352-000Medical Supportreportable segmentsegment profit2022-04-01 → 2022-06-30¥38m
jpcrp040300-q1r_E05352-000SMOreportable segmentrevenue2022-04-01 → 2022-06-30¥2.9bn
jpcrp040300-q1r_E05352-000SMOreportable segmentrevenue external2022-04-01 → 2022-06-30¥2.9bn
jpcrp040300-q1r_E05352-000SMOreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥24m
jpcrp040300-q1r_E05352-000SMOreportable segmentsegment profit2022-04-01 → 2022-06-30¥1.7bn
—segment totalrevenue2022-04-01 → 2022-06-30¥5.1bn
—segment totalrevenue external2022-04-01 → 2022-06-30¥4.8bn
—segment totalrevenue intersegment2022-04-01 → 2022-06-30¥337m
—segment totalsegment profit2022-04-01 → 2022-06-30¥1.9bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-06-30¥5.1bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-06-30¥4.8bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-06-30¥357m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-06-30¥1.8bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 402
ItemContextValueUnit
Net salesCurrentYTDDuration_jpcrp040300-q1r_E05352-000SMOReportableSegmentsMember2450000000JPY
Net salesCurrentYTDDuration_jpcrp040300-q1r_E05352-000CROReportableSegmentMember1567000000JPY
Net salesCurrentYTDDuration_jpcrp040300-q1r_E05352-000AdvancedMedicinalTreatmentReportableSegmentMember875000000JPY
Net salesCurrentYTDDuration_jpcrp040300-q1r_E05352-000MedicalSupportReportableSegmentsMember453000000JPY
Net salesCurrentYTDDuration_ReportableSegmentsMember5346000000JPY
Net salesCurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember86000000JPY
Net salesCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember5433000000JPY
Net salesCurrentYTDDuration_ReconcilingItemsMember-774000000JPY
Net salesCurrentYTDDuration4659000000JPY
Operating incomeCurrentYTDDuration_jpcrp040300-q1r_E05352-000SMOReportableSegmentsMember1100000000JPY
Operating incomeCurrentYTDDuration_jpcrp040300-q1r_E05352-000CROReportableSegmentMember36000000JPY
Operating incomeCurrentYTDDuration_jpcrp040300-q1r_E05352-000AdvancedMedicinalTreatmentReportableSegmentMember190000000JPY
Operating incomeCurrentYTDDuration_jpcrp040300-q1r_E05352-000MedicalSupportReportableSegmentsMember-49000000JPY
Operating incomeCurrentYTDDuration_ReportableSegmentsMember1278000000JPY
Operating incomeCurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember-212000000JPY
Operating incomeCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember1065000000JPY
Operating incomeCurrentYTDDuration_ReconcilingItemsMember-328000000JPY
Operating incomeCurrentYTDDuration737000000JPY
Document title cover pageFilingDateInstant
Original text (Japanese)四半期報告書
Clause of stipulation cover pageFilingDateInstant
Original text (Japanese)金融商品取引法第24条の４の７第１項
Place of filing cover pageFilingDateInstant
Original text (Japanese)関東財務局長
Filing date cover pageFilingDateInstant2023-08-07
Quarterly accounting period cover pageFilingDateInstant
Original text (Japanese)第27期第１四半期（自　2023年４月１日　至　2023年６月30日）
Company name cover pageFilingDateInstant
Original text (Japanese)株式会社アイロムグループ
Company name in english cover pageFilingDateInstantI'rom Group Co., Ltd.
Title and name of representative cover pageFilingDateInstant
Original text (Japanese)代表取締役社長　　森　豊隆
Address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)東京都千代田区富士見二丁目10番２号
Telephone number address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)03（3264）3148（代表）
Name of contact person address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)取締役　金融・経営管理センター長　菅原　明彦
Nearest place of contact cover pageFilingDateInstant
Original text (Japanese)東京都千代田区富士見二丁目10番２号
Telephone number nearest place of contact cover pageFilingDateInstant
Original text (Japanese)03（3264）3148（代表）
Name of contact person nearest place of contact cover pageFilingDateInstant
Original text (Japanese)取締役　金融・経営管理センター長　菅原　明彦
Place for public inspection cover page (text)FilingDateInstantText · Plus
Edinet codeFilingDateInstantE05352
Fund codeFilingDateInstant－
Security codeFilingDateInstant23720
Filer name in japaneseFilingDateInstant
Original text (Japanese)株式会社アイロムグループ
Filer name in englishFilingDateInstantI'rom Group Co., Ltd.
Fund name in japaneseFilingDateInstant－
Fund name in englishFilingDateInstant－
Cabinet office ordinanceFilingDateInstant
Original text (Japanese)企業内容等の開示に関する内閣府令
Document typeFilingDateInstant
Original text (Japanese)第四号の三様式
Accounting standardsFilingDateInstantJapan GAAP
Whether consolidated financial statements are preparedFilingDateInstanttrue
Industry code when consolidated financial statements are prepared in accordance with industry specific regulationsFilingDateInstantCTE
Industry code when financial statements are prepared in accordance with industry specific regulationsFilingDateInstant－
Current fiscal year start dateFilingDateInstant2023-04-01
Current period end dateFilingDateInstant2023-06-30
Type of current periodFilingDateInstantQ1
Current fiscal year end dateFilingDateInstant2024-03-31

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-03-31pass rounding
balance sheet identityconsolidated 2023-06-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-06-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-06-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-06-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-06-30pass